Phospho-LAT (Y191) Recombinant Monoclonal Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to Phospho-LAT (Y191) Recombinant Monoclonal Antibody

LAT (Linker for Activation of T cells) is a transmembrane adaptor protein essential for TCR-mediated signaling in T cells, NK cells, mast cells, and platelets . Phosphorylation at Y191 occurs following TCR activation, enabling LAT to serve as a scaffold for downstream signaling molecules . The Phospho-LAT (Y191) Recombinant Monoclonal Antibody specifically targets this post-translational modification, making it indispensable for investigating immune cell activation pathways .

3.1. Western Blot (WB)

  • Detects phosphorylated LAT at ~38 kDa in human cell lines (e.g., Jurkat, HeLa) .

  • Validated in pervanadate-treated HeLa cells and EGF-stimulated Jurkat cells .

  • Recommended dilution: 1:500–1:5,000 .

3.2. Immunohistochemistry (IHC)

  • Demonstrates strong staining in human colon carcinoma tissues .

  • Optimal dilution: 1:50–1:200 .

3.3. Functional Studies

  • Used to study LAT’s role in recruiting PLCG1, GRB2, and GRAP2 during TCR signaling .

  • Critical for investigating pathologies like autoimmune disorders and lymphomas .

Biological Significance of LAT Y191 Phosphorylation

  • Mechanism: Phosphorylation by ZAP-70 kinase enables LAT to recruit signaling molecules like PLCγ1 and Grb2, driving T-cell activation .

  • Pathological Relevance: Dysregulation linked to T-cell malignancies and immune deficiencies .

Limitations and Restrictions

  • Research Use Only: Not approved for diagnostic or therapeutic applications .

  • Species Limitations: Primarily validated for human samples; limited cross-reactivity with mouse .

Product Specs

Buffer
Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Description

Phospho-LAT (Y191) antibody CSB-RA012767A191phHU is a recombinant monoclonal antibody produced by plasmids containing the coding sequence of the LAT monoclonal antibody in host cell lines. The synthesized peptide derived from phospho-LAT at the Y191 residue was used to immunize animals for the isolation of the LAT monoclonal antibody. This recombinant antibody targeting the phosphorylated LAT at Y191 is a rabbit IgG and can react with human samples. It has undergone affinity-chromatography purification and can be used in ELISA, WB, IHC, IF, and IP applications.

LAT is a palmitoylated and membrane-associated adaptor protein that is phosphorylated at multiple tyrosine residues (e.g. Tyr132, Tyr171, Tyr191, and Tyr226) by ZAP-70 upon TCR stimulation. Phospho-LAT is activated and acts as an essential scaffold for the assembly of TCR-coupled signaling complexes, which mediate productive T cell activation.

Form
Liquid
Lead Time
Generally, we can ship the products within 1-3 business days after receiving your order. Delivery times may vary depending on the purchasing method or location. Please consult your local distributors for specific delivery times.
Synonyms
LAT; Linker for activation of T-cells family member 1; 36 kDa phospho-tyrosine adapter protein; pp36; p36-38
Target Names
LAT
Uniprot No.

Target Background

Function

LAT is essential for T-cell antigen receptor (TCR) and pre-TCR-mediated signaling, both in mature T-cells and during their development. It is also involved in FCGR3 (low affinity immunoglobulin gamma Fc region receptor III)-mediated signaling in natural killer cells and FCER1 (high affinity immunoglobulin epsilon receptor)-mediated signaling in mast cells. LAT couples activation of these receptors and their associated kinases with distal intracellular events such as mobilization of intracellular calcium stores, PKC activation, MAPK activation, or cytoskeletal reorganization through the recruitment of PLCG1, GRB2, GRAP2, and other signaling molecules.

Gene References Into Functions
  1. Plasma membrane LAT activation precedes vesicular recruitment, defining two phases of early T-cell activation. PMID: 29789604
  2. LAT1 overexpression is a negative prognostic marker linked to tumor grade, proliferating potential, and angiogenesis. It mediates intracellular transport of anticancer agents. PMID: 28815339
  3. The dimerization-dependent, cooperative binding of the growth factor receptor-bound protein 2 family to LAT may increase antigen receptor sensitivity by reducing signalosome formation at incompletely phosphorylated linker of activated T cells (LAT) molecules, thereby prioritizing the formation of complete signalosomes. PMID: 28951535
  4. Nur77 suppresses CD4(+) T cell proliferation and reveals a suppressive role for Irf4 in TH2 polarization; halving Irf4 gene-dosage leads to increases in GATA3(+) and IL-4(+) cells. PMID: 28538176
  5. LAT and phospholipase C-gamma dephosphorylation by SHP-1 inhibits natural killer cell cytotoxicity PMID: 27221712
  6. A study examined molecular mobility within LAT:Grb2:SOS assemblies on supported membranes by single-molecule tracking. Trajectory analysis reveals a discrete temporal transition to subdiffusive motion below a characteristic timescale, indicating that the LAT:Grb2:SOS assembly has the dynamical structure of a loosely entangled polymer. PMID: 29045874
  7. This report indicates that phosphotyrosine-mediated assembly of adaptor protein LAT networks yields two distinct kinetic species of the Ras activator SOS. PMID: 27370798
  8. Overexpression of LAT is associated with microcephaly. PMID: 28965845
  9. LAT and SLP-76 are randomly dispersed throughout the clusters that form upon T cell receptor engagement. PMID: 27875277
  10. This study demonstrates that inherited LAT deficiency should be considered in patients with combined immunodeficiency with T-cell abnormalities. PMID: 27522155
  11. This is the first report of a LAT-related disease in humans, manifesting as a progressive combined immune deficiency with severe autoimmune disease. PMID: 27242165
  12. Data show that LAT1 plays an important role in regulating the uptake of essential amino acids such as leucine into endometrial cancer cells. The increased ability of BCH compared to LAT1 shRNA at inhibiting Ishikawa spheroid area suggests that other LAT family members may also contribute to cell growth. PMID: 27486861
  13. Data indicate that the T cell-specific adaptor protein (TSAd) SH2 domain interacts with CD6 antigen and linker for activation of T cells protein (LAT) phosphotyrosine (pTyr) peptides. PMID: 27896837
  14. High expression of LAT1 and ASCT2 correlates with metastasis and invasion in esophageal squamous cell carcinoma. PMID: 26936531
  15. IFT20 is required for the delivery of the intracellular pool of LAT to the immune synapse in naive primary T lymphocytes. PMID: 26715756
  16. Data show that the palmitoylation mutation of linker for activation of T cells (LAT) attenuated the signal transduction induced by glycosylphosphatidylinositol-anchored CD59 antigen in T cells. PMID: 26271970
  17. HSV-1-encoded Us3 protein interrupted TCR signaling and interleukin-2 production by inactivation of the linker for activation of T cells. PMID: 25907557
  18. Patients with severe aplastic anemia had increased levels of LAT and disturbed Th1-Th2 balance. PMID: 24673455
  19. LAT is a modulator of CD3zeta and ZAP-70 tyrosine phosphorylation. PMID: 24204825
  20. Mutation of the palmitoylation site of LAT-EGFP attenuated the signal transduction of CD59 in T cells. PMID: 24200054
  21. Findings show that L-type amino acid transporter 1 is a major transporter for essential amino acids into activated human T cells. PMID: 24038088
  22. Histone hypoacetylation on the LAT promoter could inhibit LAT expression and enhance Th2 differentiation, while trichostatin A, a histone deacetylase inhibitor, promoted LAT expression and inhibited Th2 cytokine production. PMID: 23360572
  23. LAT is required to maintain calcium homeostasis in T cells. PMID: 22998346
  24. A novel function and mechanism of TRAF6 action in the T cell receptor(TCR)-LAT signaling pathway indicates that LAT also plays an adapter role in TCR/CD28-induced activation of TRAF6. PMID: 23514740
  25. LAT located at the cell surface can be recruited efficiently to activation-induced microclusters within seconds of T cell receptor (TCR) engagement. PMID: 23487428
  26. LAT cleavage may act as a regulator of TCR-mediated activation of T-cells and not only as a transducer of cell death promoting stimuli. PMID: 23240581
  27. Expression of a constitutively active Raf transgene enhances lymphoproliferation, indicating a role for the Ras-MAPK pathway in LAT-mediated autoimmune hyperproliferation. PMID: 22984075
  28. Nef employs a dual mechanism to disturb early TCR signaling by limiting the communication between LAT and SLP-76. PMID: 22802418
  29. Modeling and simulation of aggregation of membrane protein LAT with molecular variability in the number of binding sites for cytosolic Grb2-SOS1-Grb2. PMID: 22396725
  30. The segment comprising residues 112-126 of human LAT is required for its interaction with Lck. PMID: 22034845
  31. Activation of T cell antigen receptors resulted in the recruitment and phosphorylation of linker for activation of T-cells (Lat) from subsynaptic vesicles. Studies of Lat mutants confirmed that recruitment preceded Lat phosphorylation. PMID: 21642986
  32. Data show that MAL regulates membrane order and the distribution of microtubule and transport vesicle docking machinery at the IS and, by doing so, ensures correct protein sorting of Lck and LAT to the cSMAC. PMID: 21508261
  33. PECAM-1-mediated inhibition of GPVI-dependent platelet responses result from recruitment of SHP-2-p85 complexes to tyrosine-phosphorylated PECAM-1, which diminishes the association of PI3K with activatory signaling molecules Gab1 and LAT. PMID: 20723025
  34. LAT recruits Src homology 2 domain-containing leukocyte protein of 76 kDa (SLP-76) following T-cell receptor ligation and Akt kinase phosphorylation in Jurkat cells, activating the phosphoinositide 3-hydroxykinase (PI3K) signaling cascade. PMID: 21282515
  35. Elevated expression of LAT1 is associated with squamous cell carcinoma of the lung. PMID: 19068093
  36. Results indicate for the first time that LAT promotes TCR signal initiation and suggest that this adaptor may contribute to maintain active Lck in proximity of their substrates. PMID: 21152094
  37. LAT ubiquitylation is a molecular checkpoint for attenuation of T-cell signaling. PMID: 21282648
  38. These results reveal a novel role of HSP90 as a positive regulator for expression of the LAT gene in activated T cells. PMID: 21251717
  39. The adaptor LAT contains several conserved serine-based motifs, which are essential for proper signal transduction through the TCR. PMID: 20940326
  40. Studies indicate that LAT is present in membrane rafts and involved in signaling through a number of receptors other than the T cell receptor. PMID: 20875087
  41. A significant decrease in mRNA expression of the LAT gene in T cells of asthmatic patients may be due to the up-regulation of its upstream regulatory factors Lck and ZAP-70. PMID: 18683785
  42. LAT displacement from lipid rafts is a molecular mechanism by which PUFAs inhibit T cell signaling. PMID: 12029091
  43. Phosphorylation of the linker for activation of T-cells by Itk promotes recruitment of Vav. PMID: 12186560
  44. LAT plays a role in signal transduction for T cell activation and is stably associated with plasma membrane rafts. PMID: 12515827
  45. Interaction with the open-active form of Lck in lipid rafts reveals a new mechanism for the regulation of Lck in T cells. PMID: 12570875
  46. Examination of synergistic assembly in T cell plasma membrane domains. PMID: 12646565
  47. The T cell adapter molecule LAT is required for correct orientation of the microtubule-organizing center as it moves toward the interface of the T cell and antigen-presenting cell. PMID: 12847255
  48. Results reveal the basis for preferential recognition of specific LAT sites by Gads. PMID: 15029250
  49. CD3/T cell receptor complex signaling to beta 1 integrins is defective in LAT-deficient Jurkat T cells and can be restored with expression of wild-type LAT. PMID: 15100278
  50. LAB resembled a LAT molecule unable to bind phospholipase C-gamma1. PMID: 15153499

Show More

Hide All

Database Links

HGNC: 18874

OMIM: 602354

KEGG: hsa:27040

UniGene: Hs.632179

Involvement In Disease
Immunodeficiency 52 (IMD52)
Subcellular Location
Cell membrane; Single-pass type III membrane protein. Note=Present in lipid rafts.
Tissue Specificity
Expressed in thymus, T-cells, NK cells, mast cells and, at lower levels, in spleen. Present in T-cells but not B-cells (at protein level).

Q&A

What is LAT and why is phosphorylation at Y191 significant?

LAT (Linker for Activation of T-cells family member 1) is a critical palmitoylated and membrane-associated adaptor protein that becomes phosphorylated at multiple tyrosine residues upon T cell receptor (TCR) stimulation. Phosphorylation at Y191 is particularly significant as it serves as one of the key docking sites for signaling molecules that form the LAT signalosome. Upon TCR stimulation, the kinase ZAP-70 phosphorylates LAT at multiple tyrosine residues, including Y132, Y171, Y191, and Y226, allowing phosphorylated LAT to function as an essential scaffold for the assembly of TCR-coupled signaling complexes that mediate productive T cell activation . The Y191 phosphorylation site is part of the critical network that enables downstream signal propagation in T cells, making antibodies against this specific phosphorylation site valuable tools for investigating T cell signaling mechanisms.

How does a recombinant monoclonal antibody differ from conventional antibodies for detecting phospho-LAT?

Recombinant monoclonal antibodies against phospho-LAT (Y191) are produced through molecular biology techniques using plasmids containing the coding sequence of the LAT monoclonal antibody expressed in host cell lines like HEK293F . Unlike conventional antibodies produced from hybridomas, these recombinant antibodies offer several advantages for phospho-LAT research, including:

  • Higher reproducibility between batches due to the defined genetic sequence

  • Greater specificity for the phosphorylated Y191 residue due to targeted design

  • Reduced background binding and cross-reactivity

  • Consistent affinity and performance characteristics

  • More sustainable production without animal immunization for each batch

The recombinant nature ensures that researchers receive a consistent research tool with predictable binding properties across experiments and over time, which is especially important when studying dynamic phosphorylation events in signaling cascades .

What are the optimal applications for Phospho-LAT (Y191) antibodies in T cell signaling research?

Phospho-LAT (Y191) antibodies are versatile tools for investigating T cell activation and signaling pathways with several recommended applications:

ApplicationRecommended DilutionMethodological Considerations
Western Blot (WB)1:500-1:5000Optimal for quantifying phosphorylation levels and temporal dynamics after T cell stimulation
Immunohistochemistry (IHC)1:50-1:200Valuable for examining tissue sections to locate activated T cells in disease contexts
Immunofluorescence (IF)1:20-1:200Essential for visualizing LAT localization and condensate formation at the immunological synapse
Immunoprecipitation (IP)1:200-1:1000Critical for studying signalosome composition and protein interactions dependent on Y191 phosphorylation
ELISAAs recommendedUseful for high-throughput screening of phosphorylation in multiple samples

The antibody is particularly valuable in studies examining the formation of the immunological synapse, temporal dynamics of LAT phosphorylation following TCR engagement, and assembly of signaling complexes at the membrane . When designing experiments, researchers should consider the kinetics of phosphorylation at Y191, which can be transient and stimulus-dependent, requiring careful timing of sample collection after T cell activation.

How should experiments be designed to accurately capture LAT phosphorylation dynamics?

Accurately capturing LAT phosphorylation dynamics requires careful experimental design due to the rapid and transient nature of phosphorylation events. Based on current research methodologies:

  • Time course considerations: LAT phosphorylation at Y191 occurs within minutes of TCR stimulation. Design experiments with multiple early time points (30 seconds, 1, 2, 5, 10 minutes) to capture rapid phosphorylation kinetics .

  • Stimulation protocols: Use physiologically relevant stimulation methods:

    • Anti-CD3/CD28 antibodies for polyclonal activation

    • Peptide-loaded APCs for antigen-specific responses

    • Surface-bound stimuli for studying immunological synapse formation

  • Sample preparation: Quick sample processing with immediate lysis in phosphatase inhibitor-containing buffers is essential to prevent dephosphorylation artifacts.

  • Complementary techniques: TIRF microscopy can be used alongside antibody-based detection to visualize LAT condensate formation in real-time, as studies have shown Grb2 recruitment (a marker of LAT phosphorylation) occurs simultaneously with LAT condensation approximately 22.1 ± 2.0 seconds after TCR engagement .

  • Controls: Include both positive controls (strongly activated T cells) and negative controls (phosphatase-treated samples or Y191F LAT mutants) to establish detection specificity and dynamic range .

To accurately assess signaling dynamics, researchers should consider that phosphorylation at Y191 may be dependent on previous phosphorylation events at other residues, emphasizing the importance of comprehensive phosphorylation analysis across multiple sites .

How does LAT Y191 phosphorylation relate to phase separation and condensate formation in T cell signaling?

Recent research has revealed that LAT phosphorylation, including at Y191, plays a critical role in facilitating phase separation and condensate formation during T cell activation. These findings represent a paradigm shift in understanding T cell signaling:

  • LAT condensate formation: Phosphorylated LAT (pLAT) forms discrete, mobile condensates following TCR stimulation. These condensates represent high-density protein assemblies that facilitate signal transduction. Studies using TIRF microscopy have shown that LAT condensates emerge with a mean delay time of approximately 22 seconds after TCR engagement .

  • Molecular basis: The phosphorylation of multiple tyrosine residues, including Y191, creates multivalent binding sites for SH2 domain-containing proteins like Grb2. When Grb2 and SOS are present in solution with phosphorylated LAT, macroscopic network assemblies form on membranes, with estimated densities of ~4,000 molecules per square micron .

  • Dynamic properties: These LAT condensates demonstrate liquid-like properties with internal protein mobility. FRAP (Fluorescence Recovery After Photobleaching) measurements reveal recovery of intensity in photobleached spots with a diffusion coefficient (Deffective) of approximately 0.20 μm²/s .

  • Reversibility: Introduction of tyrosine phosphatases (such as YopH) rapidly reverses condensate formation within minutes, demonstrating the dynamic and phosphorylation-dependent nature of these structures .

  • Signal regulation: The formation of these condensates appears to encode antigen information, with single-molecule binding events triggering distinct LAT condensation patterns that may contribute to the ability of T cells to discriminate between antigens .

Understanding these phase separation dynamics has profound implications for how we conceptualize and investigate signaling pathways in immune cells, suggesting that spatial organization through condensation may represent a fundamental regulatory mechanism in cell signaling .

What is the interplay between tyrosine and serine phosphorylation in regulating LAT function?

Recent research has uncovered a complex interplay between tyrosine and serine phosphorylation in LAT, revealing a previously underappreciated regulatory mechanism in T cell signaling:

  • DNA-PKcs as a LAT kinase: Recent phospho-mass spectrometry studies have identified DNA-PKcs as a kinase that phosphorylates LAT at serine residues, particularly S224 and S241. These serine residues are located within conserved S/Q motifs, known DNA-PKcs consensus sites .

  • Hierarchical regulation: Phosphorylation at S224 and S241 appears to be critical for the subsequent phosphorylation of tyrosine residues, including Y191. Studies using LAT mutants (S224A, S241A, and S2A double mutant) revealed that phosphorylation at these serine residues is essential for phosphorylation at Y132, Y171, and Y191 following TCR stimulation .

  • Functional impact: LAT mutants lacking these serine phosphorylation sites showed normal proliferation but failed to rescue IL-2 production in LAT-deficient cells, indicating these sites are crucial for certain signaling outcomes .

  • Signalosome composition effects: Mass spectrometry analysis revealed that serine phosphorylation, especially at S241, regulates not only which proteins bind to LAT but also the release of proteins during T cell activation. This suggests a dual role in both recruitment and dissociation of signaling components .

  • Cell type differences: DNA-PKcs deficiency shows differential impacts on CD4+ versus CD8+ T cells, with a more pronounced effect on the cytotoxic functions of CD8+ T cells, suggesting context-dependent roles for this phosphorylation pathway .

This emerging understanding of the hierarchical relationship between serine and tyrosine phosphorylation reveals new layers of complexity in LAT signaling and may provide novel therapeutic opportunities for modulating specific T cell responses .

What are common issues when working with phospho-specific antibodies and how can they be addressed?

Working with phospho-specific antibodies like anti-phospho-LAT (Y191) presents several technical challenges that researchers should anticipate:

  • Loss of phosphorylation signal:

    • Problem: Rapid dephosphorylation during sample preparation

    • Solution: Include comprehensive phosphatase inhibitor cocktails in lysis buffers; maintain samples at 4°C during processing; consider shorter lysis times and immediate denaturation in SDS sample buffer for Western blotting applications

  • Non-specific binding:

    • Problem: Cross-reactivity with similar phospho-epitopes

    • Solution: Validate specificity using LAT-deficient cells (such as J.LAT) or Y191F mutants as negative controls; optimize antibody dilution as recommended (1:500-1:5000 for WB, 1:50-1:200 for IHC)

  • Variable signal strength:

    • Problem: Inconsistent stimulation of cells leading to variable phosphorylation levels

    • Solution: Standardize stimulation protocols; include positive controls with strong stimulation; consider time course experiments to identify optimal detection windows

  • Epitope masking:

    • Problem: Protein-protein interactions at the signalosome may obscure the Y191 epitope

    • Solution: Test different lysis conditions and detergents; consider gentle fixation methods for IF/IHC that preserve phospho-epitopes while maintaining cellular architecture

  • Sensitivity limitations:

    • Problem: Low detection sensitivity in samples with minimal phosphorylation

    • Solution: Consider signal amplification methods; use complementary approaches like Phos-tag gels or mass spectrometry for confirmation; implement proximity ligation assays for detection of low-abundance phosphorylated proteins

For optimal results, researchers should perform preliminary experiments to establish the kinetics of LAT phosphorylation in their specific experimental system, as timing is critical for capturing this transient modification .

How can phospho-LAT (Y191) antibodies be integrated with other methodologies to provide comprehensive signaling analysis?

Integration of phospho-LAT (Y191) antibody detection with complementary methodologies can provide a more comprehensive understanding of T cell signaling dynamics:

  • Multi-parametric flow cytometry:

    • Combine phospho-LAT (Y191) detection with other phospho-specific antibodies (phospho-ZAP70, phospho-PLCγ1, phospho-ERK) to assess signaling pathway activation at the single-cell level

    • Allows correlation of LAT phosphorylation with cellular phenotypes and functional outcomes

  • Advanced microscopy approaches:

    • TIRF microscopy enables visualization of membrane-proximal LAT phosphorylation events and condensate formation in real-time

    • Super-resolution microscopy (STORM, PALM) can resolve nanoscale organization of LAT signalosomes

    • Live-cell imaging with fluorescent reporters can track temporal dynamics of LAT recruitment and phosphorylation

  • Proximity-based assays:

    • Proximity ligation assays (PLA) can detect specific protein-protein interactions dependent on Y191 phosphorylation

    • FRET-based sensors can monitor conformational changes and protein associations resulting from LAT phosphorylation

  • Proteomic approaches:

    • Immunoprecipitation with phospho-LAT (Y191) antibodies followed by mass spectrometry can identify novel interaction partners

    • Phospho-proteomics can map the signaling networks downstream of LAT Y191 phosphorylation

  • Genetic approaches:

    • CRISPR-Cas9 editing to create Y191F mutants for functional studies

    • Reconstitution experiments in LAT-deficient cells to assess the specific contribution of Y191 phosphorylation to various T cell functions

By integrating these methodologies, researchers can move beyond simple detection of LAT phosphorylation to understand its spatial organization, temporal dynamics, and functional consequences in various physiological and pathological contexts .

How might differential phosphorylation patterns of LAT relate to T cell fate decisions?

Recent research suggests that differential phosphorylation patterns of LAT, including at Y191, may play a crucial role in determining T cell fate decisions and functional outcomes:

  • Kinetic proofreading and antigen discrimination:

    • The timing and magnitude of LAT phosphorylation appears to encode information about antigen quality. Studies have shown that LAT condensation occurs with a characteristic delay (~22 seconds) following TCR engagement .

    • This timing mechanism may contribute to the ability of T cells to discriminate between self and foreign antigens, with strong agonists inducing more rapid and robust LAT phosphorylation.

  • CD4+ vs. CD8+ T cell responses:

    • Differential requirements for LAT phosphorylation have been observed between CD4+ and CD8+ T cells. DNA-PKcs-dependent LAT phosphorylation appears more critical for CD8+ T cell cytotoxic functions compared to CD4+ T cells .

    • This suggests that distinct phosphorylation patterns might contribute to lineage-specific functions.

  • Effector vs. memory T cell differentiation:

    • Emerging evidence suggests that the amplitude and duration of LAT signaling may influence T cell differentiation decisions between effector and memory fates.

    • Weaker or more transient LAT phosphorylation might favor memory cell development, while stronger, sustained phosphorylation may drive terminal effector differentiation.

  • Cytokine production vs. proliferation:

    • LAT mutants lacking serine phosphorylation sites (S224A, S241A) show normal proliferation but impaired IL-2 production, indicating specific phosphorylation patterns may selectively regulate certain functional outputs .

    • The composition of the LAT signalosome appears to be differentially affected by specific phosphorylation patterns, potentially explaining these selective functional effects.

Future research should explore how combinatorial phosphorylation patterns across multiple LAT residues collectively influence T cell fate decisions in various immunological contexts, potentially leading to new therapeutic strategies for modulating specific immune responses .

What are the methodological considerations for studying LAT condensates in relation to phosphorylation status?

Studying the relationship between LAT phosphorylation and condensate formation requires specialized methodological approaches that preserve the dynamic and often transient nature of these structures:

  • Live-cell imaging systems:

    • TIRF microscopy is essential for visualizing membrane-proximal LAT condensates with minimal background

    • Spinning disk confocal microscopy allows for rapid 3D acquisition to capture condensate dynamics

    • Implement temperature-controlled stages (37°C) to maintain physiological conditions that support condensate formation

  • Fluorescent protein tagging strategies:

    • Use monomeric fluorescent proteins (mNeonGreen, mScarlet) that minimize artifacts in phase separation studies

    • Consider fluorescent protein location (N- vs C-terminal) to avoid interfering with LAT membrane localization

    • Implement bicistronic P2A vectors containing LAT-mScarleti and mNeonGreen-GRB2 to simultaneously monitor LAT and binding partners

  • Quantitative analysis approaches:

    • Develop automated image analysis pipelines to identify and track condensates over time

    • Implement FRAP (Fluorescence Recovery After Photobleaching) to measure protein mobility within condensates

    • Calculate diffusion coefficients to characterize the material properties of LAT condensates (reported Deffective of 0.20 μm²/s)

  • Reconstitution systems:

    • Consider in vitro reconstitution of LAT condensates using purified components on supported lipid bilayers

    • Systematically vary the phosphorylation state of LAT to determine the minimal requirements for condensate formation

    • Control the concentration of binding partners (e.g., 5.8 μM Grb2 and 1.45 μM SOS) to study concentration-dependent effects

  • Verification controls:

    • Use phosphatase treatments (e.g., 10 μM YopH) to confirm phosphorylation-dependence of observed condensates

    • Implement LAT mutants with altered phosphorylation sites to determine the contribution of specific residues

    • Consider LAT(4F) mutants with Y136, Y175, Y195, and Y235 mutated to phenylalanine as negative controls

These methodological considerations ensure that researchers can accurately capture and characterize the complex relationship between LAT phosphorylation status and its organization into functional condensates that mediate T cell activation .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.